Active Research Studies: Multiple Myeloma

A Phase 4, Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Newly Diagnosed Multiple Myeloma Switching from a Bortezomib-Based Triplet Induction Regimen (TOURMALINE US MM-6)
Study#: 17081 Phase III
Contact Us: For information about this clinical study, Email Us, or use our form field.

Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide plus Low dose Dexamethasone (pom/dex) in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
Study#: 18229 Phase III
Contact Us: For information about this clinical study, Email Us, or use our form field.